Acquisition

June 29, 2026 BSE Limited National Stock Exchange of India Limited The Listing Department The Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1, G Block, 25th Floor, Dalal Street Bandra Kurla Complex Fort, Mumbai 400 001 Bandra (East), Mumbai 400051 Maharashtra, India Maharashtra, India BSE Scrip Code: 544309 NSE Symbol: IKS Dear Sir/Ma’am, Sub: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Additional investment in IKS WWMG MSO LLC, an associate company of Inventurus Knowledge Solutions Inc (“IKS Inc”), a wholly owned subsidiary of the Company. With reference to the captioned subject, we would like to inform you that the Board of Directors at its Meeting held on Monday, June 29, 2026, approved additional investment (in one or more tranches) upto USD 15,000,000 by Inventurus Knowledge Solutions Inc (“IKS Inc”), a wholly owned subsidiary of the Company in IKS WWMG MSO LLC (“WWMG MSO”), an associate company of IKS Inc by subscribing upto 15,000,000 Common Units of the WWMG MSO, which will result in total holding of 63.49% of the outstanding equity interests of the WWMG MSO by IKS Inc. The relevant disclosures as required under Regulation 30 of the SEBI LODR Regulations and Part A of Schedule III thereof, read with SEBI Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 (Master Circular for compliance with the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 by listed entities) dated January 30, 2026, in relation to the aforesaid investment is enclosed herewith as Annexure - A. The aforementioned information is also available on the Company’s website at https://ikshealth.com/investor- relations/. The Board meeting started at 06:25 PM IST and concluded at 06:44 PM IST. We request you to take the same on your records Yours sincerely, For Inventurus Knowledge Solutions Limited Sameer Chavan Company Secretary and Compliance Officer Membership No. F7211 Encl: As above ANNEXURE – A DISCLOSURE UNDER REGULATION 30 OF THE SEBI LODR REGULATIONS READ WITH SEBI CIRCULAR NO. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 DATED JANUARY 30, 2026 Disclosure of Additional investment in IKS WWMG MSO LLC, an associate company of Inventurus Knowledge Solutions Inc, a wholly owned subsidiary of the Company S. Particulars Description 1. Name of the target entity, Name of the Target: IKS WWMG MSO LLC (“WWMG MSO”). details in brief such as size, Additional investment upto USD 15,000,000 by Inventurus Knowledge turnover etc. Solutions Inc (“IKS Inc”), a wholly owned subsidiary of the Company in WWMG MSO, a associate company of IKS Inc. Financial Details of WWMG MSO: Particulars FY 2025-26 USD million Revenue from operations Nil Other income 0.08 Total income 0.08 Net worth 16.02 2. Whether the acquisition Since this is a further investment by a subsidiary of the Company in its would fall within related associate company, the transaction is between two related parties of party transaction(s) and the Company. whether the promoter/ The Promoter/Promoter Group of the Company does not have any promoter group/ group interest in the entity in which the investment is being made. companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is done at “arm’s length. 3. Industry to which the Providing management, consulting, administrative, and other support entity being acquired services to physician practices that provide or arrange for the provision belongs. of professional healthcare services. 4. Objects and impact of The group is investing in WWMG MSO to strategically elevate its market acquisition (including but position from a Service provider to a transformation partner and drive not limited to, disclosure future growth creating a sustainable physician aggregation model, of reasons for acquisition enhancing the stickiness of our care enablement platform. This of target entity, if its transaction represents a strategic investment by the group intended to business is outside the strengthen its competitive positioning, expand its market influence, main line of business of and support long-term growth objectives. the listed entity) Through this investment, the group aims to drive strategic transformation across its customer base in response to evolving dynamics within the healthcare sector. Concurrently, it will enable the group to ascend the value chain, thereby enhancing its differentiation from commoditized service providers. Additionally, the investment is expected to increase the integration and long-term adoption of IKS’s care enablement platform, further reinforcing customer engagement and platform stickiness. 5. Brief details of any Not applicable. governmental or regulatory approvals required for the acquisition 6. Indicative time period for On or before March 31, 2029. completion of the acquisition. 7. Consideration - whether Cash consideration cash consideration or share swap and details of the same 8. Cost of acquisition and/or Upto USD 15,000,000/- in one or more tranches the price at which the (15,000,000 Common Units valued at USD 1 per Unit) shares are acquired. First tranche of said approved investment of upto USD 3,000,000/- will be invested on or before July 3, 2026 (3,000,000 Common Units valued at USD 1 per Unit). 9. Percentage of After completion of the said investment of USD 15,000,000, the shareholding / control shareholding of IKS Inc in WWMG MSO will increase from 48.02% to acquired and / or number 63.49%. of shares acquired. 10. Brief background about WWMG MSO was incorporated on June 12, 2025 in the United States the entity acquired in of America with the business objective of providing management, terms of products/line of consulting, administrative, and other support services to physician business acquired, date of practices that provide or arrange for the provision of professional incorporation, history of healthcare services in the United States of America. last 3 years turnover, country in which the Turnover of last 3 years: acquired entity has presence and any other Year Revenue significant information (in (in USD Million) brief). 2025-26 Nil 2024-25 Not applicable, since 2023-24 the Target was incorporated on June 12, 2025